‫
  

‬ ‫‬

‫
 ‬
‫    ‬
‫ﺗﺨﺪﻳﺮ ﺍﻟﻤﺮﺿﻰ ﺍﻟﺒﺪﻳﻨﻴﻦ‬ ‫ﺍﻟﻌﻨﻮﺍﻥ‪:‬‬
‫ﻣﻠﺤﻢ‪ ،‬ﻧﺎﻫﺪ‬ ‫ﺍﻟﻤؤﻟﻒ ﺍﻟﺮﺋﻴﺴﻲ‪:‬‬
‫ﺍﻟﺪﻏﻠﻲ‪ ،‬ﻫﻨﺪ‪ ،‬ﺃﺭﻧﺎؤﻭﻁ‪ ،‬ﻣﺤﻤﺪ ﻋﻠﻴ)ﻤﺸﺮﻑ(‬ ‫ﻣؤﻟﻔﻴﻦ ﺁﺧﺮﻳﻦ‪:‬‬
‫

‬ ‫‪2005‬‬ ‫ﺍﻟﺘﺎﺭﻳﺦ ﺍﻟﻤﻴﻼﺩﻱ‪:‬‬
‫ﺩﻣﺸﻖ‬ ‫ﻣﻮﻗﻊ‪:‬‬

‫

‬ ‫‪1 - 63‬‬

‫‪575612‬‬
‫ﺍﻟﺼﻔﺤﺎﺕ‪:‬‬
‫ﺭﻗﻢ ‪:MD‬‬
‫ﺭﺳﺎﺋﻞ ﺟﺎﻣﻌﻴﺔ‬ ‫ﻧﻮﻉ ﺍﻟﻤﺤﺘﻮﻯ‪:‬‬

‫
א 

‬ ‫
א ‬ ‫‪Arabic‬‬ ‫ﺍﻟﻠﻐﺔ‪:‬‬

‫ﺭﺳﺎﻟﺔ ﻣﺎﺟﺴﺘﻴﺮ‬ ‫ﺍﻟﺪﺭﺟﺔ ﺍﻟﻌﻠﻤﻴﺔ‪:‬‬
‫ﺟﺎﻣﻌﺔ ﺩﻣﺸﻖ‬ ‫ﺍﻟﺠﺎﻣﻌﺔ‪:‬‬
‫
‬ ‫ﺍﻟﺒﺸﺮﻱ    ‬
‫ﺍﻟﻄﺐ ‬
‫ﺍﻟﻜﻠﻴﺔ‪  ! :‬ﻛﻠﻴﺔ ‬
‫ﺳﻮﺭﻳﺎ‬ ‫ﺍﻟﺪﻭﻟﺔ‪:‬‬
‫‪Dissertations‬‬ ‫ﻗﻮﺍﻋﺪ ﺍﻟﻤﻌﻠﻮﻣﺎﺕ‪:‬‬
‫ﺍﻟﻌﻤﻠﻴﺎﺕ ﺍﻟﺠﺮﺍﺣﻴﺔ ‪ ،‬ﺍﻟﺘﺨﺪﻳﺮ ‪ ،‬ﺍﻟﺴﻤﻨﺔ ‪ ،‬ﺍﻟﺮﻋﺎﻳﺔ ﺍﻟﺼﺤﻴﺔ‬ ‫ﻣﻮﺍﺿﻴﻊ‪:‬‬
‫‬
‫‪http://search.mandumah.com/Record/575612‬‬ ‫ﺭﺍﺑﻂ‪:‬‬

‫‪  .‬‬

‫ 
‪:‬‬ ‫‪:‬‬
‫!‪#$ !    ..‬‬ ‫!‪"  ..‬‬
‫© ‪ 2020‬ﺩﺍﺭ ﺍﻟﻤﻨﻈﻮﻣﺔ‪ .‬ﺟﻤﻴﻊ ﺍﻟﺤﻘﻮﻕ ﻣﺤﻔﻮﻇﺔ‪.‬‬
‫ﻫﺬﻩ ﺍﻟﻤﺎﺩﺓ ﻣﺘﺎﺣﺔ ﺑﻨﺎﺀ ﻋﻠﻰ ﺍﻹﺗﻔﺎﻕ ﺍﻟﻤﻮﻗﻊ ﻣﻊ ﺃﺻﺤﺎﺏ ﺣﻘﻮﻕ ﺍﻟﻨﺸﺮ‪ ،‬ﻋﻠﻤﺎ ﺃﻥ ﺟﻤﻴﻊ ﺣﻘﻮﻕ ﺍﻟﻨﺸﺮ ﻣﺤﻔﻮﻇﺔ‪ .‬ﻳﻤﻜﻨﻚ ﺗﺤﻤﻴﻞ ﺃﻭ‬
‫ﻃﺒﺎﻋﺔ ﻫﺬﻩ ﺍﻟﻤﺎﺩﺓ ﻟﻼﺳﺘﺨﺪﺍﻡ ﺍﻟﺸﺨﺼﻲ ﻓﻘﻂ‪ ،‬ﻭﻳﻤﻨﻊ ﺍﻟﻨﺴﺦ ﺃﻭ ﺍﻟﺘﺤﻮﻳﻞ ﺃﻭ ﺍﻟﻨﺸﺮ ﻋﺒﺮ ﺃﻱ ﻭﺳﻴﻠﺔ )ﻣﺜﻞ ﻣﻮﺍﻗﻊ ﺍﻻﻧﺘﺮﻧﺖ ﺃﻭ ﺍﻟﺒﺮﻳﺪ‬
‫ﺍﻻﻟﻜﺘﺮﻭﻧﻲ( ﺩﻭﻥ ﺗﺼﺮﻳﺢ ﺧﻄﻲ ﻣﻦ ﺃﺻﺤﺎﺏ ﺣﻘﻮﻕ ﺍﻟﻨﺸﺮ ﺃﻭ ﺩﺍﺭ ﺍﻟﻤﻨﻈﻮﻣﺔ‪.‬‬

‫‪١‬‬
 ‫
  

‬ ‫‬
‫
 ‬
‫    ‬

‫

‬
‫

‬
‫
א 

‬ ‫
א ‬
‫
‬ ‫!        ‬

‫‬
‫‪  .‬‬

‫ 
‪:‬‬ ‫‪:‬‬
‫!‪#$ !    ..‬‬ ‫!‪"  ..‬‬

‫‪١‬‬
٢
 ‫ﺇﻫـــﺪﺍء‬






 




.«‫"!
א‬#
...‫»

א‬


....‫ א‬#-
...%&
' 
()*

'+,



./


 01‫
(
א‬2"&
3145
6&7



....:*‫
;
א‬.....38+‫
א‬9



!"<‫=
א‬-
!"
%>
9
?@




C+
AB
...%
9



.I%F
J‫"
א‬K
..GH+
 
..D E

FBE
     


...+1-
...L"MN
">O‫
א‬
    


+ E
IK"P

?;‫
א‬Q‫
א‬./


:*‫
א‬IFB+
R8/
 



...S?T+
...!" ?F


./


...
GH

‫ﻧﺎﻫﺪ‬
٣
 ‫ﻛﻠﻤﺔ ﺷﻜﺮ‬
‫  ‬
‫‪.          ! " # $‬‬
‫!(' (' &‪:%‬‬
‫&      !‪.'( )  * + ,  #$‬‬
‫&‪ .! /0 )$ - 1/23  ")  -  -‬‬
‫‪.4$ 5‬‬
‫ ‪1. /( .+ .‬‬ ‫  " ‪1  "  -6‬‬
‫( ‪.‬‬ ‫(    ‪-‬‬
‫ ‪.* +# ,
( -‬‬ ‫‪. &/‬‬

‫‪/  .‬‬

‫ﻧﺎﻫﺪ‬

‫‪٤‬‬
 ‫

‬
‫
א 
א  

‬
‫

‬
‫‪:"     1+‬‬
‫‪. :    98‬‬
‫;‪. /(   9‬‬

‫ﺍﻟﺪﺭﺍﺳﺔ ﺍﻟﻨﻈﺮﻳﺔ‪:‬‬
‫‪.  $  ( 98‬‬
‫;‪.  $ <$ 9‬‬
‫=‪.  $ >  9‬‬
‫?‪.  $  $  9‬‬
‫@‪:" $ 0    3 1 A 9‬‬

‫*    ‪. 3‬‬

‫*   !‪. 0 $/‬‬
‫* ‪.<C! D A‬‬
‫*    ‪. 2‬‬
‫*     ‪.‬‬

‫"‪.‬‬ ‫‪$ 0    1  9E‬‬

‫‪٥‬‬
 ‫‪.  ( $+  ! 9F‬‬

‫‪:   $  9G‬‬

‫* ‪.    2‬‬
‫*  ‪.1 /(  H 1‬‬
‫* ‪.$+‬‬

‫‪: J K  $  9I‬‬

‫* ‪.     " L‬‬
‫* *  (‪.‬‬
‫* ‪.$+‬‬

‫‪. ($   ( 1C* 98M‬‬

‫ﺍﻟﺪﺭﺍﺳﺔ ﺍﻟﻌﻤﻠﻴﺔ‪:‬‬
‫‪ ( $+ 2  !  10‬‬

‫‪:2 >  12‬‬

‫‪,  < 9‬‬
‫‪( 9‬‬
‫‪  $  9‬‬
‫‪ ( > 9‬‬

‫‪٦‬‬
 :N *  $ 93
.(  * 1 9
.    * 1 9
. * 1   1$(D 9

.  ( ($   ( $+ 14

.1! 1 D15

٧
‫ﺍﻟﺪﺭﺍﺳﺔ ﺍﻟﻨﻈﺮﻳﺔ‬

‫‪٨‬‬

 
(Ideal body weigh) K  " -    L$   $ ( 9
.   " *$ D RK  %;M  !$
 5  – ,  –  /0 (   (   " IBW *S
.
( 5 " U  $  +C( "   $  (  
/0 "X" "  !$ W /0 D  "Body Mass Index "  /
: $( 4  $  U$
 $   $ ;F,@ ≤ BMI
. 2   $ ?M ≤ BMI
:  BMI W  " XFM "  8,G $ Z* C
[ K
: 1J K ^($  U ; / X;8,E =;(8,G)/FM
" .0 BMI (   /2(  $  &  " $0 9
.  -     "
."5 /   U ( $ BMI  /* -   $ Z*  9

:
  6 !
 /. –    0 0 *  " L !( ^   $ $(
.D N  " $ " C*    $ N S  K –
.+

٩
 :
 7   10
W   5   C* 0  ` – 3 _  & <C! $
. !3 "    0

Sedentay life style :
 (  #  )2

K  -   5 R+ N    0 10$   
(  1$    3  (3 ^3*  + D  ! 
."5  1  "  0 $ N  0

:
8 13
"a    3 -  D* 1 $  $   $ 
 <(/ + "  ;@M " K ` 5   $ "0 S 1  
."3 " ) "  /0 - < <   $

Drugs :
9 14
– 1.   ". -   <$ +   & " 0 ` 5
." / $  &9 "  & – 1   3

:78
"
 : ; ! 15

Cushing Syndrome X   
Hypothyroidism   D+
polycystic ovary syndrome 1  ( ^ $  

١٠
 :
= 7  1<
./0 - .!  0 " H /0   $   3  ( <(/ +
.  $$   " " N  D*  

:
@ –
:@ –
   7  1>

- . 1.  .    0 1!$   $ >  :C
J.  ^ $ " $D +   "   (  H <$&
.^ $ " $D K 

:
  A!
U.2 <./A 4.   0 5 :       $ 9
. " N/( ! 
 U2 </A 4  J  0 5 : K &       $ 9
. "$ 3 ^ " *3  " /3 !

:7=#9 
 

4 .  . . C* 0 -    N S +   $/ -$   $
.  /( D!    $ 4  "$ /( 5 $!   $
= .0 . " .$ 3 0     $ 4  * " 4 
.[  $& 3& 0 W  $ 5  $  /+ 5 1 
$ $ " 2(     $   "  2 " b   " 9
^.($    >3 – N 9 </! ^L$ $Dc $
.1  

١١
 :
 
&/  CB
:  $ U     2 1 " 0 ` 5
.   ,3  + – "   $ – C : 3  9
.d3 1 – / / $/+ J –   A2  : 0  $/+ 9
–  KCK   9"  & /0 (  H N : $C!  H 9
.,!  –    
 9 $  – $  –   1 D : (  ( 9
."
.   D3 J : / 5  /20 9
.1  ( ^ $ J – " – 4 1$2 : /  9
. & ` J : / 9
. H  0 4  : $D0 9

:
   
.^& 1   ( " Z! "  3* "   1 $
.+ .D - .   ". . 3* /0   $ eC0  9
. ( K   3* /0 - ( 1C(

:
  DIET 10

.  .A ". ./0 - ( 5 /( [ 0  K&
.1  23* 
 / N 8,@MM  8,;MM /0 (  A f$ :(
" $ %8M R %=M R1 5$ %EM : !

١٢
eC.( ($ " $ >$ ;M C*   " %8M " !3 JS5
.  1    8/= " (
"2. ;/X?M < BMI Z*& `& 5 $(D K&  
. /N GMM9?MM N 23*   
.*  $  " 1$ @ 9? /0  $ 1  b5 :( 9
.>$ 8E C*  $ " " %;M – 8@
" 2  5 ( 1 0  A  ( 1$ "L$ 1  " $ 9
.  1( 23*  1 

: Exercise
D 12
.$ 4$&   4  " !  N S  b  1  
. ./0 -  2 & !  5 :  "  " h2
. long - term weight control &   "$

:behavior modification 13
^ `    "  1 0 /  / /0 (
.( -  1  – 1+& – "& " < -  
.( 1/     (/ -3 </   $ 1( :(
.( / N U   e <
.! .  $/ (  1  " e $ D + -39
1 .0 U  1 !   1) b5 ( -   4 
.$H  H (

١٣
 : Drugs
9 14
;F ≤BMI  =M ≤ BMI 2 !    ( - 0 "
.   A2 >3  DM K ^ U  
:    $ (   10 - 0 
/.  $  1 KL "   $/ 2 + + " :"  3& 9
 D/ /0 0  –  0 – /! – &  2
.1 ($   [  * +  /( W3  KL
- . U.S .  *. J  5 (Redux)dexfenfluramine 9
. ;M
" 3   U  "   " U " / " "0 -$0 5 Fenphen-
". "( D W$ + `   </+ ^ U 1!  " /
.8IIF 0   &
: ':  E F 7   orlystat 1
. Biopropen R"`.$ " Floxetine :<. 1 2 9
 *.  ""   1$/! 0 $K "  0 10$  *
.    N    A2 >3 

Weight Reductive Surgery + =(
 15

"Bariatric Surgery"
"  1+ [ 2 K 1 $   $ <$ " " H /0
.
[   " !  !    H    A ( 1 !$
;/X?M≤BMI 5  b  <$
!  1 2 U ;/X=@ ≤BMI 

١٤
.$+ ". h.2  U -KS  H  $ 1( " " < 
.1 /( " >    1C* - 3 -*/ 2
:1 /( b5 "2
ROUX N-Y - 9
. vertical banded gastroplasty 9
  A pancreatic obiliary diversion 9
gastric banding 0  - ( $ 1J 9
gastric bypass  ( 1 1J 9
.[ !$ - 1 /(/   :  1J) 9
&   C* " " % =M – ;@ Z!  - 0 !$ 1J)
!  -   A 1  "& R$  1  ($ U  "
f.  " H /0 " " !  f  + ZD   1$$
.^   !K   " ` R-   

:+  
 = C*

: 3    /0 9
CO; e  -   O; `C  -  " $ 2 _  4  9
.0 - .  .  "0    $C!  (3 -   <$$
 H 0 W  K O; `C  U3 "  J 0. 0   &
." $
.    A  N S  D   "$ / -   
 3 :  !$ ( ) FRC Z! 4  4 

١٥
- .  U. [  Z!     ( Functianal Residual capacity
. Expiratory reserve volume ) ERV Z! 4   BMI
.( !$  
 /  ( Lung Total Capacity LTC Z! U
 (.2 N : J!/  (2$    Z! -   4  9
. .i$  
. C.H) ( " +  FRC  3 :  !$ ( Z!  + 9
.$ . /    <   0 [ $$ j & ^($ CA   N S
. & Z! 4 
./0  D.   0 Z!  D /0 3 5  f   9
< U   $ / -   R ( $   0 J!$ " H
.D . $ . .    + $$ , b$ 
.Restrictive
    ` _(  0 Z! <$ [ : BMI   9
. ,3  4  3    ! >3 U N N 
 (.2 . K :C 5   /  / ( "   U 
.N : >2
.K  .3  : "k  3  1 1 A b5 H$ 9
. K N!    " Fev8R " 3 :    ( " FVC
.JD& " $  ( $ " "&

١٦
/0 :  /0   + <$$  ( $ "  :( 0 Pco; `
1 A  ( $ $ /0 ":     ! + $  ( $    
. CO;
.  1. A U   N ^    $   U "
"   ` $      "L N  >3 "0
"    Z! –   $ "
OHS "Obesity – Hypoventilation Syndrom"
: / $   
. >.3 – ".  </+ D+ –   – + –  $ 
.  J K  – " ,( –  * – N
  J K N    ,3  + U   OHS 2 :(

. OHS U    [  "  OSA 2 ,0 /0

 R  ! " %IM  Z!   $   $    ( " 9
.  ! " %EM  D OHS U !   2   $
[  " + OHS 2 5    Z!  "
. - ($     ! :/  <$ 

:   &  
N/* e*      " $ 2 _    9
U <  </! e -   4  $ extracellular volume
." -  

١٧
5 .!  i8MM/ =9; 5  J K / N  "  9
./ "k 5  f   " X  ! + / M,M8  !$ </! e -  
. / ; – 8,@  !$ </! e -   N S X@M 5 ! 
N .    3 ` O; `C  N </! e -   " 9
.[ ( $ !$ " &$
N. "  " " ( , / K N/ H  "  9
." ( ,  0 W  K %;M
" %FM9EM $ $ 4   3*     A2 >3 9
.1
.2 " %8M9@ $ $ 4     A2 >3 9
.2$!   . A2. - .  <$ X8M " -   
. ./; $ / ?9=
& Z! :K !  _* 0 $  $/! 1 : C   9
.  1$2 –CO; -   –
.  $/!   Z! 5 [ 0  K& /
". / $ </! e -   " 4  R /+ / " $  9
A.2   U   " "  R" ( ,  " K  $
:. .+ R 3) N N( A2 >3 $   
.  (   -  $ 1 A
.0 .$/! .  <2 "    "  2 `
.   - -*/ K " 2(

١٨
N Z*.& " %@M9;M  RN ($ /$!  >3 4 
- K $ "  D -D /0   </! + "k  2   $
.   U  ( $  & " $/  2$!  3 : /0 ":   
.   A2 </! e  C$  
 . . *K . -     "  " $ " :1 :  +  9
. ( $  .2$!  3 : /0 ":  " $  -   U " $
. "  3 $ `
 .3 : "k. - .  .  *K   ,  "  2 JS5 
.$2 "  2$! 
N . 0 " .$    *K -   " 1 : K  1   9
 .2$!  .3 :  N S  $/+ / N  " $  2   $
.  J K ` U   "  J K  ( $
.$/+ ^. . U  " 0  2   $   `
,.  . 0 $. "  +  $/+ 1JD! J < "$
." (
 .  -   <$$   $/ !  1 A/ ^( N "  9
Z.! $ ( N N  >3  N S  " 
.  1 ( ^$!   S &
 ( ($ D*   1D$ $D) $ >3 :C 9
. C* D* U $  :  ( N K* `
 –   -  b $ <$ 5   ( _( - ( $
.! ( - & A2 >3 U "$ * A2 >3 – 

١٩
 :6G&B : *
:.C  "  &      D  K   <2 9
 $ $ ""  & /0 (  H K   " N J   
. 2   $ ^ 0
-K U  N &  D  K D  <2 " 9
" Ischemic heart disease" 3+) </! ^ 4 

: D   
`. "   U "$ * A2       $ ^ 9
4  $ -   N ( i ) *L U - ( 1  PH ^3* 
. $ 3$ $D) $    R   N ( ,/!
D   1$ U$ - ( 1    $   9
%IM " D*  * -$ ($      - ( 1 
" $*   (/ " 2 " D 2 JS5 "
;,@ " + PH. ;@ K   N ( _
.  $ .2 . 0  0 $ $  " $ _    9
.$ .:  ( Z3 b : "  N &  2
.  " K   $ _  ,(   5
(2.* " . " .$ . 0  $ 3 : <2 $   9
 . $ 10*  : 4   2   $ (  ( 1
. /  l

٢٠
 :   #
  /0 KS " "     1 A " 0 <$   $
:  ! < `  
. $  "  $  (   ( , 98
.3 h  `3   ! 9;
.N3 (/$ N 9=
. &  > N 9?
Altantoaxial N. ! 3 D3 $+ N!3 ( (
 D.   - H  *2 "+  <$$  " "
.N K
 .  - D! $+$ D3 b5 $  " " 
.[ 2   : /0
.  " . R"+. 1. $ [  " " " 3 h 9
-.* f.  . $ "/ R" / " *$ [ ! 2 "  
.-  /0 (/$ * `    - A
.   0 " "    -  `
" .$ 0 "N    ,3  + "   -K  2)$  b5
.[ $(D  * J K      $  ( +

٢١
 :
=

4.  " $/. [    /( +  3D " $ b U + "
. H  3  /0 -   0 –   L$ "3D  [ $H  
.eC($ " /
" .$ . $ D  ZD* b5 1   h2  A " W 
. D  H   D
D. >!$ " /( $+ "  $/ + 1 D <  <
." $ ZD* "  A " [ $/ KS + ` "& " $ b

:+  
  CH

. A . N S. " .$ 0  2    3 1 A " 9
J  > /0 KS     3 1 A b 0    1$
:"2
–  / J20&  –  / –    – </! e -  
.C$ 1 $$ $ – /  J Z!
.  & ". AD >    J /    & 0 $ 9
. ./      R  $  KL +  0   / 
.>  -    :  
. . .& ( D " Z!  >  >3 9
. "  + ) ( – 1 $  $ – "$  K "  3D U3
.[ : D *S

٢٢
./0 KS. " ". $ 3 :  2    3 1 A 9
. $$ </!    &
1 . /H & .K ! .2 . C0 <.  .    & 9
<. .    1C03  1 4  + R"  
. ! !  " /0 [ 0 0
. K " /0 0     & 0 Z!  < `
.2 0  A " !$ 3   "0 -(   & ZD 9
." $
91. $  $ " * < $     /    & [ 9
D   "* $ >  `/ "1  – " $ K
- .  3D  + " " ( Z*& 0 W /0 5   0
." 0 0
" "  $ /   + ) 1 */ $ $ l) 0 D "
. [ : e ` " RD J$ U l& *L  N S
b.5 J.0 " 1.  1. : + R0 ;? 1 * J0
. ( $ D U " 10 ?9; -  C* ^  1 *
. ". $. $   0 J0k$ hD  $$/ $ $
D 0 R ! ! " <   D 0  IBW K
.N ( Z* W /0  5
 3D " l 0 D  >    J$ 0   & 9
 .2   $   "  Z*& RN ( Z*/ W /0 5   (

٢٣
 " .( Z*.& " $   "  - * $  (  
."  0 X/ X/ 8,@ – 8,; J0k$ hD `
". , /0 10 ( ` J$ /   /2( 1 * 9
/2.( J.*) .!  ! ! " , /0 ,  K
.<H
 ..  l.. Z! .. N ..$ N .. "..  Z..! 9
. Lignocaine .
 .( N/ N  "  -     $    /  3D 9
 . 4.    N/ /*    RGRF $ h
. l) "
.  + ) 1 */ " $ _  N $ <C!  A 9
.5 .0 .5 " $ _  K 5 " / Z+  <C! 4 
. /3 "  (  / _(  N/   4  $ 1 L$
. "/3  "  U  
 $/ 1 KL W ,  " N  > " %@ "/ 3  `/ 9
. 0
. /3   "/  )  

٢٤

Powered by TCPDF (www.tcpdf.org)